Short‐term prognostic value of initial serum levels of interleukin‐10 in patients with acute myocarditis

[1]  M. Isobe,et al.  National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[2]  Y. Aizawa,et al.  Th1/Th2 balance alteration in the clinical course of a patient with acute viral myocarditis. , 2001, Japanese circulation journal.

[3]  M. Kodama,et al.  Early and long-term mortality of the clinical subtypes of myocarditis. , 2001, Japanese circulation journal.

[4]  J. Miyazaki,et al.  Protection Against Autoimmune Myocarditis by Gene Transfer of Interleukin-10 by Electroporation , 2001, Circulation.

[5]  S Sasayama,et al.  Cytokine gene therapy for myocarditis by in vivo electroporation. , 2001, Human gene therapy.

[6]  R. Holubkov,et al.  Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy , 2001, Circulation.

[7]  M. Kodama,et al.  Predictors of Disease Course in Patients With Acute Myocarditis , 2000, Circulation.

[8]  R. Hruban,et al.  Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. , 2000, The New England journal of medicine.

[9]  A. Matsumori,et al.  Treatment of experimental viral myocarditis with interleukin-10. , 1999, Circulation.

[10]  M. Kodama,et al.  Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. , 1998, Circulation research.

[11]  Y. Yazaki,et al.  Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus B3 , 1997, The Journal of pathology.

[12]  A. Matsumori,et al.  Protective role of interleukin-12 in viral myocarditis. , 1997, Journal of molecular and cellular cardiology.

[13]  S. Goto,et al.  Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. , 1997, Journal of molecular and cellular cardiology.

[14]  B. McManus,et al.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. , 1995, The New England journal of medicine.

[15]  R. A. Johnson,et al.  Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. , 1985, The New England journal of medicine.